User contributions for Hilda Mahmoudi
Jump to navigation
Jump to search
12 June 2014
- 14:0414:04, 12 June 2014 diff hist +11 Chronic obstructive pulmonary disease epidemiology and demographics No edit summary
- 14:0214:02, 12 June 2014 diff hist −1 Chronic obstructive pulmonary disease epidemiology and demographics →Economical Impact
- 13:5913:59, 12 June 2014 diff hist +12 Chronic obstructive pulmonary disease epidemiology and demographics →Economical Impact
- 13:5813:58, 12 June 2014 diff hist +501 Chronic obstructive pulmonary disease epidemiology and demographics →Economical Impact
3 June 2014
- 18:5318:53, 3 June 2014 diff hist +326 Middle East respiratory syndrome coronavirus infection overview →Epidemiology and Demographics
22 October 2013
- 18:1218:12, 22 October 2013 diff hist 0 PCI: classification of the lesion →Type B1 current
- 16:3716:37, 22 October 2013 diff hist +11 Coronary angiography ACC-AHA characteristics of type A, B, and C coronary lesions No edit summary
- 16:3616:36, 22 October 2013 diff hist +25 Coronary angiography ACC-AHA characteristics of type A, B, and C coronary lesions →Type C Lesions (Low Success, <60%; High Risk)
21 October 2013
- 19:2819:28, 21 October 2013 diff hist +4 Coronary artery dominance No edit summary
- 19:2719:27, 21 October 2013 diff hist +495 Coronary artery dominance No edit summary
16 October 2013
- 14:3814:38, 16 October 2013 diff hist +210 TIMI myocardial perfusion grade 0.5 No edit summary
- 14:3614:36, 16 October 2013 diff hist +17 TIMI myocardial perfusion grade 0.5 No edit summary
- 14:3514:35, 16 October 2013 diff hist +275 N TIMI myocardial perfusion grade 0.5 Created page with "{{SI}} {{CMG}} ==Overview== Minimal ground glass appearance (blush) or opacification of the myocardium in the distribution of the artery.Minimal blush is being defined as be..."
- 14:3114:31, 16 October 2013 diff hist +2 Coronary angiography →How to Assess Myocardial Perfusion
- 14:3014:30, 16 October 2013 diff hist +40 Coronary angiography →How to Assess Myocardial Perfusion
1 October 2013
23 September 2013
- 15:1315:13, 23 September 2013 diff hist −1,699 High density lipoprotein complete list of trials →Other trials
- 15:1215:12, 23 September 2013 diff hist +4 High density lipoprotein complete list of trials →CETP Inhibitors
- 15:1015:10, 23 September 2013 diff hist +1,591 High density lipoprotein complete list of trials →CETP Inhibitors
20 September 2013
- 20:3520:35, 20 September 2013 diff hist +1 High density lipoprotein complete list of trials →Reconstituted HDL Infusion
- 20:3420:34, 20 September 2013 diff hist 0 High density lipoprotein complete list of trials →CETP Inhibitors
- 15:2315:23, 20 September 2013 diff hist +19 High density lipoprotein complete list of trials →Reconstituted HDL Infusion
- 15:2115:21, 20 September 2013 diff hist +19 Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes No edit summary
- 15:2015:20, 20 September 2013 diff hist +119 N MDCO 216 ←Redirected page to Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes current
- 15:1915:19, 20 September 2013 diff hist +119 N ETC 216 ←Redirected page to Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes current
- 15:1915:19, 20 September 2013 diff hist +11 Apo A-1 Milano ←Redirected page to Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes current
- 15:1815:18, 20 September 2013 diff hist 0 m Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes Hilda Mahmoudi moved page A Safety and Efficacy Study of AEGR-733 to Treat Homozygous Familial Hypercholesterolemia (FH) to Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes
- 14:3914:39, 20 September 2013 diff hist −369 High density lipoprotein complete list of trials →CETP Inhibitors
- 14:3414:34, 20 September 2013 diff hist +25 High density lipoprotein complete list of trials →Reconstituted HDL Infusion
- 14:3114:31, 20 September 2013 diff hist −4 High density lipoprotein complete list of trials →Reconstituted HDL Infusion
- 14:3014:30, 20 September 2013 diff hist −23 High density lipoprotein complete list of trials →Reconstituted HDL Infusion
- 14:2914:29, 20 September 2013 diff hist +168 N CSL-112 Trial - Phase 2a Hilda Mahmoudi moved page CSL-112 Trial - Phase 2a to A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients current
- 14:2914:29, 20 September 2013 diff hist 0 m A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients Hilda Mahmoudi moved page CSL-112 Trial - Phase 2a to A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients
- 14:2814:28, 20 September 2013 diff hist −1 High density lipoprotein complete list of trials →Reconstituted HDL Infusion
- 14:2714:27, 20 September 2013 diff hist −17 High density lipoprotein complete list of trials →Reconstituted HDL Infusion
- 14:2614:26, 20 September 2013 diff hist +85 High density lipoprotein complete list of trials →Reconstituted HDL Infusion
- 14:2414:24, 20 September 2013 diff hist +23 Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes No edit summary
- 14:2414:24, 20 September 2013 diff hist +108 N Apo A-1 Milano ←Redirected page to A Safety and Efficacy Study of AEGR-733 to Treat Homozygous Familial Hypercholesterolemia (FH)
- 14:2214:22, 20 September 2013 diff hist +108 N Infusion of Apo A-1 Milano Hilda Mahmoudi moved page Infusion of Apo A-1 Milano to A Safety and Efficacy Study of AEGR-733 to Treat Homozygous Familial Hypercholesterolemia (FH)
- 14:2214:22, 20 September 2013 diff hist 0 m Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes Hilda Mahmoudi moved page Infusion of Apo A-1 Milano to A Safety and Efficacy Study of AEGR-733 to Treat Homozygous Familial Hypercholesterolemia (FH)
- 14:1114:11, 20 September 2013 diff hist +6 High density lipoprotein complete list of trials →Reconstituted HDL Infusion
- 14:0614:06, 20 September 2013 diff hist +237 High density lipoprotein complete list of trials →Reconstituted HDL Infusion
- 13:5413:54, 20 September 2013 diff hist +194 High density lipoprotein complete list of trials →Reconstituted HDL Infusion
- 13:4413:44, 20 September 2013 diff hist +41 High density lipoprotein complete list of trials →Reconstituted HDL Infusion
- 13:4113:41, 20 September 2013 diff hist +607 High density lipoprotein complete list of trials →Reconstituted HDL Infusion
- 13:3213:32, 20 September 2013 diff hist +37 High density lipoprotein complete list of trials →Reconstituted HDL Infusion
- 13:3013:30, 20 September 2013 diff hist +4 High density lipoprotein complete list of trials →Reconstituted HDL Infusion
- 13:2613:26, 20 September 2013 diff hist +105 High density lipoprotein complete list of trials →Reconstituted HDL Infusion
19 September 2013
- 18:4718:47, 19 September 2013 diff hist −9 High density lipoprotein complete list of trials →CETP Inhibitors
- 18:4518:45, 19 September 2013 diff hist −18 High density lipoprotein complete list of trials No edit summary